KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cvs Health (CVS) Long-Term Debt Repayments (2016 - 2025)

Cvs Health's Long-Term Debt Repayments history spans 15 years, with the latest figure at $20.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Repayments fell 99.0% year-over-year to $20.0 million, compared with a TTM value of $3.6 billion through Dec 2025, down 2.08%, and an annual FY2025 reading of $3.6 billion, down 23.97% over the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $20.0 million at Cvs Health, down from $2.8 billion in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $3.0 billion in Q1 2021, with the low at $14.0 million in Q1 2022.
  • Average Long-Term Debt Repayments over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2022.
  • Year-over-year, Long-Term Debt Repayments surged 29575.0% in 2021 and then tumbled 99.54% in 2022.
  • Tracing CVS's Long-Term Debt Repayments over 5 years: stood at $2.4 billion in 2021, then tumbled by 99.34% to $16.0 million in 2022, then skyrocketed by 2600.0% to $432.0 million in 2023, then surged by 362.96% to $2.0 billion in 2024, then plummeted by 99.0% to $20.0 million in 2025.
  • Per Business Quant, the three most recent readings for CVS's Long-Term Debt Repayments are $20.0 million (Q4 2025), $2.8 billion (Q3 2025), and $19.0 million (Q2 2025).